ロード中...
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
BACKGROUND: The current guidelines in Sweden regarding individuals with a clinically actionable (i.e. pathogenic or likely pathogenic) germline TP53 variant recommend patients to take part of the national Swedish P53 Study (SWEP53). METHODS: The study comprises a patient registry (mandatory for all...
保存先:
| 出版年: | Hered Cancer Clin Pract |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6958585/ https://ncbi.nlm.nih.gov/pubmed/31956380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13053-020-0133-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|